Skip to main content

Swiss National Bank

Bank

Position in NBIX — Neurocrine Biosciences Inc

CIK 1582202 ZURICH, V8

Position in NBIX

as of Mar 31, 2026 · filed May 7, 2026
Position Value
$38,547,124
-$2,270 QoQ
Shares Held
292,600
+7.7% QoQ
Ownership
0.291%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Swiss National Bank holds $531,346,390 across 28 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (7.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 NBIX
Neurocrine Biosciences Inc
This page
292,600 $38,547,124

All Filings in NBIX

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $38,547,124 292,600
2025-12-31 $38,549,394 271,800
2025-09-30 $40,050,414 285,300
2025-06-30 $37,631,586 299,400
2025-03-31 $31,576,300 285,500
2024-12-31 $38,943,450 285,300
2024-09-30 $34,416,214 298,700
2024-06-30 $40,557,582 294,600
2024-03-31 $40,576,064 294,200
2023-12-31 $40,226,328 305,300
2023-09-30 $35,302,500 313,800
2023-06-30 $33,212,460 352,200
2023-03-31 $38,514,210 380,500
2022-12-31 $46,426,328 388,700
2022-09-30 $43,995,049 414,227
2022-06-30 $40,252,123 412,927
2022-03-31 $38,515,031 410,827
2021-12-31 $30,629,431 359,627
2021-09-30 $35,767,428 372,927
2021-06-30 $37,276,187 383,027
2021-03-31 $33,133,075 340,700
2020-12-31 $32,071,410 334,600
2020-09-30 $33,021,344 343,400
2020-06-30 $42,309,600 346,800
2020-03-31 $29,383,725 339,500